首页> 外文期刊>Clinical & translational oncology : >Anti-tumor effect of endostatin in a sleep-apnea mouse model with tumor
【24h】

Anti-tumor effect of endostatin in a sleep-apnea mouse model with tumor

机译:肿瘤睡眠呼吸暂停小鼠模型中内皮抑素的抗肿瘤作用

获取原文
获取原文并翻译 | 示例
       

摘要

BackgroundObstructive sleep apnea (OSA) is associated with cancer incidence and mortality. The underlying mechanism is unclear. This study aims to evaluate the influence of intermittent hypoxia (IH), a novel hallmark of OSA, on tumor and to access the anti-tumor effect of endostatin on a mouse model with OSA.MethodsThe C57BL/6J mice were randomly classified into four groups: control (normoxia) (CTL), control plus endostatin (CTL+ED), IH, and IH plus endostatin (IH+ED). Mice in IH and IH+ED groups were subjected to IH 8h per day in 5weeks. Lewis lung cancer cells were injected into the flank of each mouse after 1week of IH exposure. Endostatin was also intraperitoneally injected after tumor volume reached about 200mm(3). The maximum standard uptake values (SUVmax) were detected by micro-positron emission tomography-computed tomography (micro-PET-CT) imaging prior and post-endostatin administration. Microvessel density (MVD) and vascular endothelial growth factor (VEGF) were determined for evaluating the anti-tumor effect of endostatin among the normoxia and IH conditions.ResultsMice had higher SUVmax in the IH group than the CTL group (p<0.01). When compared with mice in the CTL group, those in the IH group had significantly greater MVD values (p<0.001). The SUVmax can be attenuated by endostatin both in the CTL (p<0.01) and IH conditions (p<0.001). When compared with CTL group, mice in the IH group had increased MVD values (p<0.001) and VEGF expression both at mRNA (p<0.05) and protein levels (p<0.001 in western blotting results). Treatment with endostatin attenuated serum and tissue VEGF levels, lowering the MVD values. As compared to normoxia condition, the endostatin-therapeutic effects were more significant under the IH condition (p<0.05 in western blotting results).ConclusionsMicro-PET-CT imaging is a promising non-invasive technique to evaluate the tumor metabolic characteristics under IH condition in vivo. The anti-tumor effect of endostatin under IH condition is superior to that ofthe normoxia condition.
机译:Backgroundof结构睡眠呼吸暂停(OSA)与癌症发病率和死亡率有关。潜在的机制尚不清楚。本研究旨在评估间歇性缺氧(IH),OSA的新标志,对肿瘤的影响,并在用OSA的小鼠模型中获取内皮抑素的抗肿瘤作用。将C57BL / 6J小鼠随机分为四组:对照(Normoxia)(CTL),对照加内皮素(CTL + ED),IH和IH Plus内抑素(IH + ED)。 IH和IH + ED组的小鼠每天在5周中每天进行IH 8H。在IH暴露后1周后,将Lewis肺癌细胞注射到每只小鼠的侧面。在肿瘤体积达到约200mm(3)后,内皮抑素也腹膜内注射。通过微正电子发射断层摄影 - 计算断层扫描(微宠物CT)成像预造影和后骨抑制素给药来检测最大标准摄取值(SUVMAX)。测定微血管密度(MVD)和血管内皮生长因子(VEGF)来评估内皮抑素和IH条件的抗肿瘤作用。探测器在IH组中具有比CTL组更高的SUVMAX(P <0.01)。与CTL组中的小鼠相比,IH组中的那些具有明显更大的MVD值(P <0.001)。 Suvmax可以在CTL(P <0.01)和IH条件下通过内皮抑素衰减(P <0.001)。与CTL组相比,IH组中的小鼠在mRNA(P <0.05)和蛋白质水平(P <0.001在蛋白质印迹结果中)增加了MVD值(P <0.001)和VEGF表达。用内抑素减毒治疗血清和组织VEGF水平,降低MVD值。与常氧疾病相比,内抑素治疗效果在IH条件下更显着(Western印迹结果中的P <0.05)。Conclusionsmicro-PET-CT成像是一种有前途的非侵入性技术,可评估IH条件下的肿瘤代谢特性体内。 IH病症下的内皮抑素蛋白的抗肿瘤作用优于常氧病症。

著录项

  • 来源
  • 作者单位

    Xiamen Univ Zhongshan Hosp Dept Resp Med Xiamen Fujian Peoples R China;

    Xiamen Univ Zhongshan Hosp Dept Resp Med Xiamen Fujian Peoples R China;

    Fujian Med Univ Clin Med Coll 2 Fuzhou Fujian Peoples R China;

    Xiamen Univ Zhongshan Hosp Dept Resp Med Xiamen Fujian Peoples R China;

    Xiamen Univ Zhongshan Hosp Dept Resp Med Xiamen Fujian Peoples R China;

    Fujian Med Univ Clin Med Coll 2 Fuzhou Fujian Peoples R China;

    Xiamen Univ Dept Comp Sci Xiamen 361005 Peoples R China;

    Xiamen Univ Zhongshan Hosp Dept Resp Med Xiamen Fujian Peoples R China;

    Fujian Med Univ Zhangzhou Affiliated Hosp Dept Resp Med Xiangcheng Dist Zhangzhou Peoples R;

    Xiamen Univ Zhongshan Hosp Dept Resp Med Xiamen Fujian Peoples R China;

    Xiamen Univ Zhongshan Hosp Dept Resp Med Xiamen Fujian Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

    Intermittent hypoxia; Sleep apnea; Tumor; Endostatin; Positron emission tomography;

    机译:间歇性缺氧;睡眠呼吸暂停;肿瘤;内皮抑制;正电子发射断层扫描;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号